NeueHealth, Inc. (NYSE:NEUE) Short Interest Down 25.8% in February

NeueHealth, Inc. (NYSE:NEUE) was the recipient of a large drop in short interest in February. As of February 28th, there was short interest totalling 9,200 shares, a drop of 25.8% from the February 13th total of 12,400 shares. Currently, 0.3% of the shares of the stock are short sold. Based on an average trading volume of 38,400 shares, the days-to-cover ratio is currently 0.2 days.

NeueHealth Price Performance

NeueHealth stock opened at $4.71 on Tuesday. NeueHealth has a 12-month low of $3.79 and a 12-month high of $7.66. The stock has a market capitalization of $38.98 million, a P/E ratio of -0.09 and a beta of 0.56. The firm’s 50-day moving average is $7.21 and its two-hundred day moving average is $6.01.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada decreased their price target on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research note on Monday, December 9th.

Insider Buying and Selling at NeueHealth

In other NeueHealth news, CFO Jay Matushak sold 4,448 shares of the firm’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $6.74, for a total transaction of $29,979.52. Following the completion of the transaction, the chief financial officer now directly owns 41,592 shares in the company, valued at approximately $280,330.08. This trade represents a 9.66 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO George Lawrence Mikan III sold 31,798 shares of the firm’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $233,079.34. Following the sale, the chief executive officer now directly owns 146,539 shares in the company, valued at $1,074,130.87. This represents a 17.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 110,033 shares of company stock worth $774,560. 64.30% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On NeueHealth

Several hedge funds have recently modified their holdings of the stock. Partners Group Holding AG acquired a new stake in shares of NeueHealth in the third quarter worth approximately $463,000. Northern Trust Corp boosted its position in shares of NeueHealth by 66.8% in the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after acquiring an additional 13,074 shares during the last quarter. Finally, Virtu Financial LLC acquired a new stake in shares of NeueHealth in the fourth quarter worth approximately $76,000. 63.88% of the stock is owned by institutional investors and hedge funds.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.